Identity
- Trade Name
- Reia FDA UDI
- Generic Name
- Vaginal applicator, reusable FDA UDI
- Device Name
- Size 3 Applicator FDA UDI
- Model / Reference
- AA01-3 FDA UDI
- Description
- Size 3 Applicator FDA UDI
Identifiers
- Primary DI / UDI-DI
- 00860012119387 FDA UDI
- FDA Product Code
- HGD FDA UDI
- GMDN Term
- Vaginal applicator, reusable FDA UDI
Classification
- Device Class
- Class I FDA UDI
- Regulation Number
- 884.4520 FDA UDI
- Commercial Distribution
- In Commercial Distribution FDA UDI
Clinical & Handling
Sterile
No
FDA UDI
Single Use
No
FDA UDI
Implantable
No
FDA UDI
Contains Latex
No
FDA UDI
Prescription Use
No
FDA UDI
Over-the-Counter
Yes
FDA UDI
Convenience Kit
No
FDA UDI
Combination Product
No
FDA UDI
HCT/P
No
FDA UDI
Premarket Exempt
Yes
FDA UDI
Lot / Batch Number
Yes
FDA UDI
Serial Number
No
FDA UDI
Expiration Date
No
FDA UDI
Manufacturing Date
No
FDA UDI
Category: Vaginal applicator, reusable
Reia by Reia, LLC — Class I — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS
Similar devices
Also classified as Vaginal applicator, reusable.
- Premarin (conjugated estrogens) vaginal cream — Wyeth Pharmaceuticals LLC · Class I
- Ring applicator — SOPRO-COMEG GmbH · Class II
- Pixie Cup — Pixie Cup, LLC · Class I
- Premarin (conjugated estrogens) vaginal cream — Wyeth Pharmaceuticals LLC · Class I
- Ring applicator — SOPRO-COMEG GmbH · Class II
- Applicator — SOPRO-COMEG GmbH · Class II
- CLEOCIN® (clindamycin phosphate vaginal suppositories) Vaginal Ovules — Pharmacia & Upjohn Co. · Class I
- Vaginal Applicator — MAI/GENESIS · Class I
Authorization Coverage (1 country)
Regulatory Authorizations
United States Pending data
FDA UDI
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| FDA UDI | United States | FDA UDI | Registered in GUDID | Class I | Pending data |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- Reia, LLC
Sources (1)
- FDA UDI 9ddf32d3-2b6f-4149-832d-558ad6fc48c1 33 fields · synced Jun 8, 2026